Sinopharm Group(国药控股)
Fast facts
- Year Founded
- 2003
Source: Sinopharm Websitewww.sinopharmgroup.com.cn/1263.html
- HQ Location
- Shanghai, China
- Publicly Traded?
- Yes
Source: Hong Kong Stock Exchangewww.hkex.com.hk/Market-Data/Securities-Prices/Equities/Equities-Quote
- Overseas Operations
- Yes
Sinopharm signed an agreement in July 2021 to provide 170 million COVID-19 vaccine doses to COVAX, the global initiative to distribute vaccines to low- and middle-income countries. The company has reportedly also reached cooperation deals with the United Arab Emirates, Serbia, Morocco and Hungary to produce its vaccines locally. Its chairman said it is now in discussion with African, Southeast Asian, and American countries to build local vial-filling and packaging plants.Source: China Dailywww.chinadaily.com.cn/a/202109/27/WS61510727a310cdd39bc6baae.html
- US Sanctions
- No
- Military Affiliation in China
- Yes
China has disclosed military-to-military shipments of Covid-19 shots manufactured by state-owned drugmaker Sinopharm totaling hundreds of thousands of doses. Many of the recipients, like Zimbabwe and Ethiopia, are important players in Chinese leader Xi Jinping’s trillion-dollar Belt and Road infrastructure initiative.Source: The Wall Street Journalwww.wsj.com/articles/chinas-army-furnishes-foreign-militaries-with-covid-19-vaccines-11636369726
Revenue
2020 revenue was reported in RMB and was converted to dollars using the exchange rate from November 5, 2021.Source: Sinopharm 2020 Annual Reportwww1.hkexnews.hk/listedco/listconews/sehk/2021/0423/2021042300115.pdf
Valuation
Valuation is reported as market capitalization. It was converted from HKD using the exchange rate from June 26, 2022 13:50:01.Source: Yahoo Financefinance.yahoo.com/quote/SHTDY/key-statistics
Employees
Source: Sinopharm Websitewww.sinopharm.com/1398.html
Sinopharm Group Co., Ltd. is a state-owned drug researcher, distributor, and manufacturer best known globally for its COVID-19 vaccine, which was the No. 3 most-used in the world as of September 2021.
Sinopharm’s vaccine, the first Chinese jab to be given emergency approval by the World Health Organization, has made up a significant proportion of the 2 billion doses administered in China and 693 million sent abroad, along with peer company Sinovac Biotech’s shot. Also as of September, Sinopharm’s vaccines have been approved in 11 countries and authorized for emergency use or market access in 107 countries and regions.
The company has an annual production capacity of 7 million doses and is currently developing an mRNA vaccine. It is a subsidiary of Sinopharm Industrial Investment, which was a joint venture of Fosun Pharmaceutical and state-owned China National Pharmaceutical.
Sinopharm has been listed on the Hong Kong Stock Exchange since 2009, with the ticker symbol 1099:HK.
Source: Fortunefortune.com/2021/08/31/china-covid-vaccine-sinovac-sinopharm-delta-variant-effective/Source: Financial Timeswww.ft.com/content/91cbc7ef-808d-448a-a832-2384f045dc35Source: China Dailywww.chinadaily.com.cn/a/202109/27/WS61510727a310cdd39bc6baae.html
-
- Name
- Ownership
-
- Sinopharm Industry Investment
Source: Qichachawww.qcc.com/firm/0604fbd802d077219bc569df2934eca9.html
- 50.36%
- Sinopharm Industry Investment
-
- China National Pharmaceutical Group
Source: Qichachawww.qcc.com/firm/0604fbd802d077219bc569df2934eca9.html
- 6.64%
- China National Pharmaceutical Group
-
- Citigroup
Source: Qichachawww.qcc.com/firm/0604fbd802d077219bc569df2934eca9.html
- 0.27%
- Citigroup
- Mr. Liu Jingzhen, Chairman Mr. Liu Yong, President, Deputy Secretary of Party Committee
- Mr. Li Yang, Vice President
- Mr. Jiang Xiuchang, Vice President
- Mr. Lian Wanyong, Vice President
- Mr. Cai Maisong, Vice President
- Ms. Li Xiaojuan, Chief Financial Officer
- Mr. Zhou Song, Vice President
- Mr. Zhou Xudong, Vice President
- Mr. Chen Zhanyu, Vice President
- Mr. Xu Shuangjun, Non-Executive Vice President
Sinopharm signed an agreement in July 2021 to provide 170 million COVID-19 vaccine doses to COVAX, the global initiative to distribute vaccines to low- and middle-income countries. The company has reportedly also reached cooperation deals with the United Arab Emirates, Serbia, Morocco and Hungary to produce its vaccines locally. Its chairman said it is now in discussion with African, Southeast Asian, and American countries to build local vial-filling and packaging plants.
Source: China Dailywww.chinadaily.com.cn/a/202109/27/WS61510727a310cdd39bc6baae.html
Sinopharm Group Sanctions
While at this time it appears that this company is not the subject of any U.S. or other global sanctions, it is important to note that Chinese companies tend to have more opaque organizational structures than their Western peers. Chinese companies' affiliated brands, operating units, and overseas subsidiaries are not always obvious or even identifiable. Given this, a Chinese company may not be the subject of sanctions, but one of its subsidiaries may be, thus making it difficult to accurately ascertain a company's full sanctions status.
The latest news on Sinopharm Group from SupChina
China’s Fujian Province battles Delta flare-up as vaccine rollout approaches 80% goal
Also: Will China pivot to mRNA vaccines?
The politicalization of COVID vaccines in Taiwan
A recent outbreak of COVID-19 in Taiwan has exposed flaws in the government’s pandemic response plans. While the ruling Democratic Progressive Party attempts to get things under control, its political enemies are circling.
China reaches 40% vaccine coverage, aims for 80% by year-end
In other Chinese vaccine news, Sinovac Biotech becomes the second China-based company to win WHO approval for its shot, and Chinese vaccine makers promise even greater supply for developing countries.
China domestic vaccination campaign roars ahead, now at four times peak U.S. daily rate
True to form for the world’s most populous nation, China is now administering eye-popping numbers of COVID-19 vaccinations. In a span of nine days, 100 million people in China recently received a shot.
WHO approves China’s Sinopharm vaccine for emergency use
Sinopharm’s COVID-19 vaccine is the first Chinese-made shot to ever be approved for emergency use by the World Health Organization. The step affirms China’s growing scientific power, but is expected to have limited impact on vaccine supply in the short term.
Philippines foreign minister tweets profane insults at China over maritime dispute
After a month of lodging repeated diplomatic protests against the presence of Chinese fishing boats in disputed waters, the Philippines foreign minister took a less diplomatic approach on Twitter. He was gently rebuked by President Rodrigo Duterte for being “rude and disrespectful” to the Philippines’ “benefactor.”
China CDC director worries about ‘not high’ vaccine efficacy, but says his remarks were taken out of context
Gao Fu, the director of China’s CDC, suggested mixing vaccines, adding doses, and looking into mRNA technology to improve the efficacy of COVID-19 shots. He later insisted that he wasn’t “admitting” to a low effectiveness of Chinese vaccines.
China further embraces Iran with 25-year cooperation agreement
China will reportedly receive a steady supply of oil from Iran in exchange for large multi-sector investments in the Iranian economy. The deal is the latest move by Beijing to increase its influence in the Middle East.
China might soon have four approved COVID-19 vaccines
On the same day that U.S. regulators cleared the way for the Johnson & Johnson vaccine to become the country's third approved COVID-19 shot, two more Chinese companies applied for public rollouts of their vaccines in China.
The meaning of China’s vaccine diplomacy
Chinese vaccines against COVID-19 are providing low- and middle-income countries with solutions in a time of need. They have helped fill a void left by Europe and the U.S.
The latest news on Sinopharm Group from across the web
Vietnam takes Sinopharm vaccines to ease Ho Chi Minh City's woes
China’s vaccine diplomacy in Vietnam: Though many in the Southeast Asian country were distrustful of China’s vaccines, millions of donated Sinopharm jabs may be working to spur the local economy and strengthen the socialist neighbors’ ties.
Sinopharm crosses 'critical threshold' on vaccines
Chinese drugmaker Sinopharm reached an annual production capacity of 7 billion COVID-19 vaccine doses last month, as significant progress has been made in upgrading existing vaccines to tackle new variants and in developing vaccines of different technologies, the head of the company said on Sunday.
Chinese vaccine safe for children as young as 3, says study
The data was released as a fresh cluster of cases in primary school children has intensified the debate about vaccinating under-12s.
China’s Sinopharm seeks to develop its own mRNA Covid vaccine
Biotech’s jab could give the technology a boost amid concerns over efficacy of conventional shots
How do China's COVID vaccines fare against the Delta variant?
Sinovac and Sinopharm may not work as well against Delta—but they are still working.
Sinopharm Covid Vaccine Seen as Less Effective in Bahrain Study
The vaccine made by China’s Sinopharm was less effective than others at preventing infection, hospitalization and death, especially among people over 50, according to a study by the kingdom of Bahrain and Columbia University researchers.
Peru study finds Sinopharm COVID vaccine 50.4% effective against infections
A two-dose COVID-19 vaccine from China's Sinopharm was 50.4% effective in preventing infections in health workers in Peru when it was seeing a surge in cases fuelled by virus variants, and booster shots can be considered, a study found.
The Logic of China’s Vaccine Diplomacy
An in-depth look at where China’s vaccines are going hints at the motivations behind the campaign.
Producers study vaccine efficacy on mutation with additional third-dose injection
Data collected for Chinese COVID-19 vaccines have not shown that mutated coronavirus sequences have a significant impact on the efficacy of those vaccines, but China's vaccine manufacturers are conducting follow-up experiments of their COVID-19 vaccines on the mutated strains, as some have started injecting a third shot and monitor its efficacy.
China's Sinopharm to raise vaccine production to 3 billion per year
China's pharmaceutical giant Sinopharm will expand COVID-19 vaccine production capacity to 3 billion doses per year, becoming the world's biggest vaccine producer for the virus, Chairman of Sinopharm Group Yu Qingming told the media.
Coronavirus vaccines could bring Africa and China closer
To many Africans, Europe has been greedy, hoarding vaccinations produced in the West to combat the coronavirus pandemic. The repercussion is that Africa could cozy up further to a generous Asian giant — China.
Why Serbia Embraced China’s COVID-19 Vaccine
Belgrade had little choice but to welcome China’s vaccine diplomacy. That could have lasting diplomatic consequences.
As Delta Variant Spreads, China Lacks Data on Its Covid-19 Vaccines
The efficacy of the Chinese vaccines against the Delta variant will affect how soon China can open its borders and impact the course of the pandemic throughout much of the developing world, where many countries are reliant on Chinese shots.
They Relied on Chinese Vaccines. Now They’re Battling Outbreaks.
More than 90 countries are using Covid shots from China. Experts say recent infections in those places should serve as a cautionary tale in the global effort to fight the disease.
China’s road to 1 billion vaccine doses includes eggs, water bottles, free rides and new concern.
The enormous inoculation drive is administering 17 million shots a day. Demand has risen after a recent outbreak in the southern city of Guangzhou.
Vietnam approves China's Sinopharm vaccine for emergency use
Supply shortage pushed Hanoi to allow doses despite Beijing tensions
Vietnam approves China's Sinopharm vaccine for use against COVID-19
Vietnam has approved China's Sinopharm vaccine for use against COVID-19, state media reported on Friday, making it the third shot to be endorsed in the Southeast Asian country that is tackling a new outbreak of infections.
Study: Sinopharm COVID-19 vaccines appear safe, effective
JAKARTA, Indonesia (AP) — Two vaccines made by China’s Sinopharm appear safe and effective against COVID-19, according to a study published in a medical journal. Scientists had been waiting for more details about the two vaccines, even though they already are being used in many countries, and one recently won the backing of the World Health Organization for emergency use.
Sinopharm's two COVID-19 shots effective, study says
Two COVID-19 vaccines from China's Sinopharm showed more than 70% efficacy against symptomatic cases, but it remains unclear how much protection they provide against severe or asymptomatic cases, according to the first detailed result of a large late-stage study published to the public.
World’s Most Vaccinated Nation Is Spooked by Covid Spike
Seychelles has seen a surge in coronavirus cases even though much of its population was inoculated with China’s Sinopharm vaccine.
South Africa Covid Vaccination to Add Sputnik V, Sinopharm Shots
South Africa plans to buy Russia’s Sputnik V vaccines and shots developed by China’s Sinopharm Group Co. Ltd as it steps up efforts to tackle the coronavirus.
After Dropping AstraZeneca From Its Vaccine Plan, the Africa CDC Looks to Sinopharm For Jabs - The China Africa Project
The Africa Center for Disease Control is reportedly in
Zimbabwe receives first vaccines from Sinopharm in China
HARARE, Zimbabwe (AP) — Zimbabwe has received its first COVID-19 vaccines with the arrival early Monday of an Air Zimbabwe jet carrying 200,000 Sinopharm doses from China...
Abu Dhabi launches new COVID-19 vaccine plant with China's Sinopharm
A new factory in Abu Dhabi will start manufacturing a COVID-19 vaccine from Chinese pharmaceutical giant Sinopharm later this year under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42 (G42).
UAE firm to manufacture Chinese Sinopharm vaccine from April
A firm based in the United Arab Emirates will start commercial production of China's Sinopharm vaccines in April, under a deal announced on Sunday.
100 million doses of China Sinopharm's COVID-19 vaccines supplied globally
Two COVID-19 vaccines developed by subsidiaries of China National Pharmaceutical Group (Sinopharm) have hit a combined 100 million doses of supply around the world, a Sinopharm affiliate said late on Friday.
China donates 400,000 doses of Sinopharm vaccine to Niger
China donated 400,000 doses of the COVID-19 vaccine developed by Sinopharm to Niger on Sunday, the first vaccines the West African nation has received, Niger's presidency said.
China asks visa applicants to get inoculated with Chinese-made vaccines.
A new rule for foreigners applying in Hong Kong for visas gives preference to those who choose shots produced in China.
Early Adopter U.A.E. Starts Giving Third Dose of Sinopharm Vaccine Amid Efficacy Concerns
Health authorities in the United Arab Emirates have begun administering a third dose of the Chinese-made shots after doctors said some recipients haven’t generated enough protective antibodies.
Hungary pays big for a Chinese vaccine.
The European nation has agreed to pay $36 per dose of the Sinopharm vaccine, according to contracts put online by a Hungarian official.
Over 43 million doses of Sinopharm's COVID-19 vaccines used globally: state media
(This story corrects last paragraph to read China has promised to donate vaccines to several countries, not they have been delivered)
Zimbabwe Embarks on National Vaccination Drive With Donated Sinopharm Jabs - The China Africa Project
Less than one week after Zimbabwe took delivery of 200,000 doses of COVID-19 vaccines from China, the government announced an additional 75,000 are on their way from India. Even though vaccines are now starting to make their way into people's arms, it may be a while before the public gets ...
China Deploys Covid-19 Vaccine to Build Influence, With U.S. on Sidelines
Beijing and its companies are assembling a chain of airplanes, warehouses and trucks to deliver refrigerated doses to the developing world, the latest link in its push to build global influence; “knight in shining armor.”
First 550,000 doses of Chinese Sinopharm's vaccine arrive in Hungary
The first 550,000 doses of the Sinopharm COVID-19 vaccine have arrived in Budapest, a leading health official said on Tuesday, as Hungary prepares to become the first EU country to roll out the Chinese vaccine.
China’s Covid-19 Vaccine Diplomacy Boosts Its Influence in Europe
Frustrated by rollout stumbles on the continent, some small European countries are turning to Beijing for help fighting Covid-19, a trend that could expand China’s presence in a strategically important region.
China’s Covid-19 Vaccine Makers Struggle to Meet Demand
Chinese vaccine makers are racing to meet the needs of China and a growing list of countries Beijing has pledged to supply, but there are signs that inoculations are going slower than planned.
Opinion | It’s Time to Trust China’s and Russia’s Vaccines
They, too, work, and they can help fill shortages everywhere.
Sinopharm Covid Vaccine: Pakistan says China's Sinopharm vaccine not effective for people over 60 years | World News - Times of India
Pakistan News: Pakistan on Thursday said that China's Sinopharm vaccine is not effective for people over 60 years of age, a day after it began its countrywide corona
Sinopharm vaccine effective against South African variant: study
But researchers find that shot is weaker than when used against original virus
China's Sinopharm vaccine offered to elite few in UAE tourist deal
Knightsbridge Circle offer is first evidence of Covid-19 vaccine being used to attract tourists
Hungary signs deal for Chinese Sinopharm's COVID-19 vaccine, first in EU
Hungary became the European Union's first member to approve China's Sinopharm COVID-19 vaccine, sealing a deal on Friday for 5 million doses just a week after becoming the first EU member to buy Russia's Sputnik V vaccine.
China’s Sinopharm, Sinovac Covid-19 vaccines assessed by WHO for emergency use
WHO reviews the firms for ‘emergency use listing’, which could expedite their approval by countries’ regulators, with a decision expected in March at earliest.
China Wanted to Show Off Its Vaccines. It’s Backfiring.
Delays, inconsistent data, spotty disclosures and the country’s attacks on Western rivals have marred its ambitious effort to portray itself as a leader in global health.
Moderna Lags China's Sinovac, Sinopharm in WHO Covid Vaccine Approval
As concern over vaccine disparity across the world deepens, the World Health Organization is struggling to keep pace with rich western countries in green-lighting shots for use -- slowing down the Covax initiative which poorer countries are relying on for inoculation.
Serbia receives million doses of China's Sinopharm COVID-19 vaccine
A plane carrying one million doses of Sinopharm's COVID-19 vaccine arrived on Saturday in Serbia, making it the first European country to receive the Chinese vaccine for mass inoculation programmes.
Two senior managers from one of China's top vaccine companies have resigned
Sinopharm, a state-owned giant behind China's coronavirus vaccine development, announced its chairman left the board as of Tuesday.
Seychelles rolls out COVID-19 vaccination using China's Sinopharm, says president's office
Seychelles has started vaccinating its population against COVID-19 with doses from China's Sinopharm vaccine, President Wavel Ramkalawan said.
Jordan approves emergency use of China’s Sinopharm coronavirus vaccine
‘It is the second vaccine available for use in Jordan, after the Pfizer/BioNTech vaccine,’ said Jordan’s Food and Drug administration chief.
Brazil Embraces Chinese Covid-19 Vaccine as Cases Soar
Brazilian President Jair Bolsonaro’s administration has backed down from its criticism of Chinese vaccines and agreed to buy up to 100 million doses of a shot being developed by China’s Sinovac, as Latin America confronts a postholiday surge in Covid-19 cases.
China Approves Covid-19 Vaccine as It Moves to Inoculate Millions
Sinopharm, a state-controlled company, said its candidate had a 79 percent efficacy rate in interim late-stage trials. But crucial questions remained unanswered.
Sinopharm Covid-19 vaccine undergoing regulatory review, report says
Centre for Drug Evaluation reviewing company’s application to release one of its two candidates to market, Chinese news website says.
China's Sinopharm Covid vaccine: how effective is it and where will it be rolled out?
Trials have claimed 86% efficacy, but Peru has suspended tests because of ‘an adverse event’ and there is concern about lack of transparency
Kuwait Approves Pfizer-BioNTech, Bahrain Registers Sinopharm
Bahrain has approved Chinese-made Sinopharm Group Co.’s vaccine for widespread usage on Sunday while neighboring Kuwait authorized the use of Pfizer Inc. and BioNTech SE’s vaccine.
China's Covid vaccine from Sinopharm is 86% effective, UAE says
The announcement was thin on details, however, and did not mention any side effects experienced by patients.
China’s Sinopharm Seeking Approval for COVID-19 Vaccine
The company’s two coronavirus vaccine candidates have already been administered to over 1 million people, according to CEO Liu Jingzhen.
China's Sinopharm says data 'better than expected" from unit's COVID-19 vaccine trials
China National Pharmaceutical Group (Sinopharm) said on Wednesday the data from large-scale, late-stage clinical trials for its unit's COVID-19 vaccine are "better than expected".
Sinopharm says may be able to make over 1 billion coronavirus vaccine doses in 2021
China National Pharmaceutical Group (Sinopharm), one of several Chinese firms developing coronavirus vaccines, said it may have the capacity to produce more than 1 billion doses in 2021, Chairman Liu Jingzhen said on Tuesday.
China Drugmaker Gives Unproven Covid-19 Vaccine to Students Going Abroad
China is expanding distribution of coronavirus vaccines outside of clinical trials, with a state-owned company offering them to students going abroad amid a campaign by officials to boost public confidence in homegrown inoculations.
Peru, Morocco to test China Sinopharm's COVID-19 vaccine in Phase 3 trial
Authorities in Peru and Morocco have approved Phase 3 clinical trials for a potential COVID-19 vaccine developed by China National Biotec Group (CNBG), the company said late on Thursday on Chinese social media platform WeChat.
China Sinopharm's potential COVID-19 vaccine triggers antibodies in clinical trials: journal
A coronavirus vaccine candidate developed by a unit of China National Pharmaceutical Group (Sinopharm) appeared to be safe and triggered antibody-based immune responses in early and mid-stage trials, researchers said.
China's Sinopharm begins late stage trial of COVID-19 vaccine in UAE
Chinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Abu Dhabi using up to 15,000 volunteers, the government in the capital of the United Arab Emirates said on Thursday.
China's Sinopharm unit completes new COVID-19 vaccine plant, doubles capacity
China National Biotec Group (CNBG) said on Wednesday it has completed construction of a new plant for coronavirus vaccines, doubling its capacity to more than 200 million doses a year, as it prepares late-stage trials of its potential COVID-19 shots.
China's Sinopharm to extend its reach into Southeast Asia
State-backed company to launch $150m fund to look for opportunities
Walgreens Takes Stake in Chinese Pharmacy Chain
Walgreens Boots Alliance agreed to take a 40% stake in Chinese retail-pharmacy company Sinopharm Holding Guoda Drugstores for about $418 million.
Sinopharm executives targeted in China corruption probe
China’s largest drug distributor has become the most prominent domestic target in a corruption probe into the promotional methods of several foreign and local pharmaceutical companies.
